. The company’s pipeline contains 4 scientific-stage therapies. Its most Sophisticated drug applicant is ROS1 inhibitor taletrectinib for dealing with lung cancer. Nuvation is completing two stage two pivotal studies on taletrectinib. That isn’t what I’m most proud of. I’m prouder that I’ve turned much more than twenty of https://financefeeds.com/whales-continue-to-accumulate-fartcoin-as-price-passes-1-and-investors-bet-big-on-solaxy/